Abeona Therapeutics PE Ratio 2010-2022 | ABEO
Current and historical p/e ratio for Abeona Therapeutics (ABEO) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Abeona Therapeutics PE ratio as of January 27, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Abeona Therapeutics PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2023-01-27 |
2.65 |
|
0.00 |
| 2022-09-30 |
3.04 |
$-18.31 |
0.00 |
| 2022-06-30 |
5.20 |
$-18.58 |
0.00 |
| 2022-03-31 |
7.88 |
$-20.50 |
0.00 |
| 2021-12-31 |
8.43 |
$-21.25 |
0.00 |
| 2021-09-30 |
28.00 |
$-14.25 |
0.00 |
| 2021-06-30 |
39.00 |
$-14.50 |
0.00 |
| 2021-03-31 |
47.00 |
$-14.00 |
0.00 |
| 2020-12-31 |
39.25 |
$-22.75 |
0.00 |
| 2020-09-30 |
25.50 |
$-26.00 |
0.00 |
| 2020-06-30 |
72.88 |
$-32.75 |
0.00 |
| 2020-03-31 |
52.50 |
$-41.50 |
0.00 |
| 2019-12-31 |
81.75 |
$-38.25 |
0.00 |
| 2019-09-30 |
56.50 |
$-39.75 |
0.00 |
| 2019-06-30 |
119.50 |
$-39.50 |
0.00 |
| 2019-03-31 |
184.00 |
$-33.50 |
0.00 |
| 2018-12-31 |
178.50 |
$-28.25 |
0.00 |
| 2018-09-30 |
320.00 |
$-24.00 |
0.00 |
| 2018-06-30 |
400.00 |
$-18.75 |
0.00 |
| 2018-03-31 |
358.75 |
$-17.75 |
0.00 |
| 2017-12-31 |
396.25 |
$-16.50 |
0.00 |
| 2017-09-30 |
426.25 |
$-16.50 |
0.00 |
| 2017-06-30 |
160.00 |
$-15.25 |
0.00 |
| 2017-03-31 |
125.00 |
$-15.00 |
0.00 |
| 2016-12-31 |
121.25 |
$-16.00 |
0.00 |
| 2016-09-30 |
150.00 |
$-12.75 |
0.00 |
| 2016-06-30 |
59.00 |
$-15.50 |
0.00 |
| 2016-03-31 |
64.00 |
$-14.50 |
0.00 |
| 2015-12-31 |
84.00 |
$-12.75 |
0.00 |
| 2015-09-30 |
101.25 |
$-173.50 |
0.00 |
| 2015-06-30 |
126.50 |
$-272.50 |
0.00 |
| 2015-03-31 |
78.50 |
$-906.00 |
0.00 |
| 2014-12-31 |
86.25 |
$-978.50 |
0.00 |
| 2014-09-30 |
350.00 |
$-903.75 |
0.00 |
| 2014-06-30 |
375.00 |
$-850.00 |
0.00 |
| 2014-03-31 |
687.50 |
$-175.00 |
0.00 |
| 2013-12-31 |
312.50 |
$62.50 |
5.00 |
| 2013-09-30 |
562.50 |
$1,137.50 |
0.49 |
| 2013-06-30 |
600.00 |
$400.00 |
1.50 |
| 2013-03-31 |
612.50 |
$-212.50 |
0.00 |
| 2012-12-31 |
300.00 |
$-650.00 |
0.00 |
| 2012-09-30 |
562.50 |
$-1,637.50 |
0.00 |
| 2012-06-30 |
812.50 |
$-850.00 |
0.00 |
| 2012-03-31 |
1412.50 |
$-387.50 |
0.00 |
| 2011-12-31 |
1800.00 |
$-262.50 |
0.00 |
| 2011-09-30 |
2562.50 |
$-100.00 |
0.00 |
| 2011-06-30 |
2562.50 |
$-1,137.50 |
0.00 |
| 2011-03-31 |
2762.50 |
$-937.50 |
0.00 |
| 2010-12-31 |
3100.00 |
$-737.50 |
0.00 |
| 2010-09-30 |
2437.50 |
$-1,862.50 |
0.00 |
| 2010-06-30 |
2450.00 |
$-1,287.50 |
0.00 |
| 2010-03-31 |
3137.50 |
$-1,675.00 |
0.00 |
| 2009-12-31 |
4112.50 |
$-2,025.00 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.045B |
$0.003B |
|
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
|
